• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气道中的嘌呤能信号转导。

Purinergic signaling in the airways.

机构信息

Autonomic Neuroscience Centre, University College Medical School, Royal Free Campus, London, UK.

出版信息

Pharmacol Rev. 2012 Oct;64(4):834-68. doi: 10.1124/pr.111.005389. Epub 2012 Aug 10.

DOI:10.1124/pr.111.005389
PMID:22885703
Abstract

Evidence for a significant role and impact of purinergic signaling in normal and diseased airways is now beyond dispute. The present review intends to provide the current state of knowledge of the involvement of purinergic pathways in the upper and lower airways and lungs, thereby differentiating the involvement of different tissues, such as the epithelial lining, immune cells, airway smooth muscle, vasculature, peripheral and central innervation, and neuroendocrine system. In addition to the vast number of well illustrated functions for purinergic signaling in the healthy respiratory tract, increasing data pointing to enhanced levels of ATP and/or adenosine in airway secretions of patients with airway damage and respiratory diseases corroborates the emerging view that purines act as clinically important mediators resulting in either proinflammatory or protective responses. Purinergic signaling has been implicated in lung injury and in the pathogenesis of a wide range of respiratory disorders and diseases, including asthma, chronic obstructive pulmonary disease, inflammation, cystic fibrosis, lung cancer, and pulmonary hypertension. These ostensibly enigmatic actions are based on widely different mechanisms, which are influenced by the cellular microenvironment, but especially the subtypes of purine receptors involved and the activity of distinct members of the ectonucleotidase family, the latter being potential protein targets for therapeutic implementation.

摘要

嘌呤能信号在正常和患病气道中的重要作用和影响的证据现在已经毋庸置疑。本综述旨在提供嘌呤能途径在上呼吸道和下呼吸道及肺部的参与的最新知识,从而区分不同组织的参与,如上皮衬里、免疫细胞、气道平滑肌、血管、周围和中枢神经支配以及神经内分泌系统。除了嘌呤能信号在健康呼吸道中具有大量功能的大量说明外,越来越多的证据表明,气道损伤和呼吸系统疾病患者的气道分泌物中 ATP 和/或腺苷水平升高,这证实了嘌呤作为具有临床重要意义的介质的观点,导致促炎或保护反应。嘌呤能信号参与肺损伤和多种呼吸系统疾病和病症的发病机制,包括哮喘、慢性阻塞性肺疾病、炎症、囊性纤维化、肺癌和肺动脉高压。这些看似神秘的作用基于广泛不同的机制,这些机制受细胞微环境的影响,但特别是涉及的嘌呤受体亚型和核苷酸酶家族的不同成员的活性,后者是治疗实施的潜在蛋白质靶标。

相似文献

1
Purinergic signaling in the airways.气道中的嘌呤能信号转导。
Pharmacol Rev. 2012 Oct;64(4):834-68. doi: 10.1124/pr.111.005389. Epub 2012 Aug 10.
2
Purinergic signalling in the lung: important in asthma and COPD?肺中的嘌呤能信号传导:在哮喘和慢性阻塞性肺疾病中起重要作用?
Curr Opin Pharmacol. 2004 Jun;4(3):207-14. doi: 10.1016/j.coph.2004.01.010.
3
Purinergic transmission in blood vessels.血管中的嘌呤能传递。
Auton Neurosci. 2015 Sep;191:48-66. doi: 10.1016/j.autneu.2015.04.007. Epub 2015 Apr 25.
4
Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.肝和肺脉管系统的共有特征包括在宿主防御和炎症调节中可比的嘌呤能信号转导反应。
Am J Physiol Gastrointest Liver Physiol. 2021 Aug 1;321(2):G200-G212. doi: 10.1152/ajpgi.00406.2020. Epub 2021 Jun 9.
5
Neuroanatomical evidence for a putative autocrine/paracrine signaling system involving nicotinic acetylcholine receptors, purinergic receptors, and nitric oxide synthase in the airways.神经解剖学证据表明,在气道中存在一种假定的自分泌/旁分泌信号系统,涉及烟碱型乙酰胆碱受体、嘌呤能受体和一氧化氮合酶。
J Neurosci Res. 2012 Apr;90(4):849-59. doi: 10.1002/jnr.22817.
6
Does Adenosine Triphosphate via Purinergic Receptor Signalling Fuel Pulmonary Fibrosis?三磷酸腺苷通过嘌呤能受体信号传导会引发肺纤维化吗?
J Innate Immun. 2025;17(1):44-55. doi: 10.1159/000543083. Epub 2024 Dec 11.
7
Regulation of airway nucleotides in chronic lung diseases.慢性肺部疾病中气道核苷酸的调节
Subcell Biochem. 2011;55:75-93. doi: 10.1007/978-94-007-1217-1_4.
8
Purinergic receptors in airway hydration.气道水合作用中的嘌呤能受体。
Biochem Pharmacol. 2021 May;187:114387. doi: 10.1016/j.bcp.2020.114387. Epub 2021 Jan 5.
9
Purinergic signaling in wound healing and airway remodeling.嘌呤能信号在伤口愈合和气道重塑中的作用
Subcell Biochem. 2011;55:139-57. doi: 10.1007/978-94-007-1217-1_6.
10
Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.囊性纤维化中的过度炎症和气道表面液体脱水:嘌呤能系统作为治疗靶点。
Inflamm Res. 2021 Jun;70(6):633-649. doi: 10.1007/s00011-021-01464-z. Epub 2021 Apr 27.

引用本文的文献

1
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma.美泊利珠单抗改变城市哮喘儿童鼻气道2型和上皮炎症的基因调控网络。
Nat Commun. 2025 Sep 2;16(1):8191. doi: 10.1038/s41467-025-63629-2.
2
sulfolipid-1 (Sl-1) increases the excitability of mouse and human TRPV1-positive sensory neurons in a YM254890-reversible fashion.硫脂-1(Sl-1)以一种可被YM254890逆转的方式增加小鼠和人类TRPV1阳性感觉神经元的兴奋性。
bioRxiv. 2025 Jun 29:2025.06.28.662105. doi: 10.1101/2025.06.28.662105.
3
Activation of Adenosine Triphosphate-Gated Purinergic 2 Receptor Channels by Transient Receptor Potential Vanilloid Subtype 4 in Cough Hypersensitivity.
瞬时受体电位香草酸亚型4激活三磷酸腺苷门控嘌呤能2型受体通道介导咳嗽超敏反应
Biomolecules. 2025 Feb 14;15(2):285. doi: 10.3390/biom15020285.
4
Extracellular purines in lung endothelial permeability and pulmonary diseases.细胞外嘌呤与肺内皮通透性及肺部疾病
Front Physiol. 2024 Aug 20;15:1450673. doi: 10.3389/fphys.2024.1450673. eCollection 2024.
5
Different localization of P2X4 and P2X7 receptors in native mouse lung - lack of evidence for a direct P2X4-P2X7 receptor interaction.P2X4 和 P2X7 受体在天然小鼠肺中的不同定位 - 缺乏直接 P2X4-P2X7 受体相互作用的证据。
Front Immunol. 2024 Jun 17;15:1425938. doi: 10.3389/fimmu.2024.1425938. eCollection 2024.
6
Release of ATP in the lung evoked by inhalation of irritant gases in rats.大鼠吸入刺激性气体时肺内 ATP 的释放。
J Appl Physiol (1985). 2024 Sep 1;137(3):581-590. doi: 10.1152/japplphysiol.00137.2024. Epub 2024 Jun 27.
7
Calcium Signaling in Airway Epithelial Cells: Current Understanding and Implications for Inflammatory Airway Disease.气道上皮细胞中的钙信号传导:当前认识及其对炎症性气道疾病的影响
Arterioscler Thromb Vasc Biol. 2024 Apr;44(4):772-783. doi: 10.1161/ATVBAHA.123.318339. Epub 2024 Feb 22.
8
Degranulation of human mast cells: modulation by P2 receptors' agonists.人肥大细胞脱粒:P2 受体激动剂的调节。
Front Immunol. 2023 Oct 5;14:1216580. doi: 10.3389/fimmu.2023.1216580. eCollection 2023.
9
DT-0111: a novel P2X3 receptor antagonist.DT-0111:一种新型 P2X3 受体拮抗剂。
Purinergic Signal. 2023 Sep;19(3):467-479. doi: 10.1007/s11302-023-09930-5. Epub 2023 Mar 22.
10
Adenosine A Receptor (AAR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice.腺嘌呤核苷 A 受体(AAR)激动剂治疗小鼠博来霉素诱导的肺纤维化。
Int J Mol Sci. 2022 Nov 1;23(21):13300. doi: 10.3390/ijms232113300.